Feed Preview

Influential

GRIP1 in Myeloid Cells in Neuroinflammation

GRIP1 in Myeloid Cells in Neuroinflammation diagram by Robiso22
Robiso22

GRIP1 is a glutamate receptor interacting protein 1 and myeloid cells consists of granulocytes and monocytes, before they have differentiated and are derived from hematopoietic stem cells. The interaction between GRIP1 and myeloid cells in inflammation is in the early stages. Here is the latest research on GRIP1 and myeloid cells in inflammation.

Top 20 most recent papers
Radiology

Myeloperoxidase Molecular MRI Reveals Synergistic Combination Therapy in Murine Experimental Autoimmune Neuroinflammation

RadiologySeptember 4, 2019
Anning LiJohn Chun-Hao Chen
5
1
The Journal of Experimental Medicine

Gasdermin D in peripheral myeloid cells drives neuroinflammation in experimental autoimmune encephalomyelitis

The Journal of Experimental MedicineAugust 31, 2019
Sheng Shu LiShuo Yang
24
2
23
1
Journal of Autoimmunity

Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation

Journal of AutoimmunityJune 12, 2019
Hsing-Chuan TsaiMay Htwe Han
2
5
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology

TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models

FASEB Journal : Official Publication of the Federation of American Societies for Experimental BiologyAugust 3, 2019
Ying GuoHai-yan Lou
3
1
5
The Journal of Clinical Investigation

C-type lectin receptors Mcl and Mincle control development of multiple sclerosis-like neuroinflammation

The Journal of Clinical InvestigationNovember 14, 2019
Marie N'diayeMaja Jagodic
1
Current Alzheimer Research

Role of TREM2 in Alzheimer's disease and its consequences on β-amyloid, Tau and neurofibrillary tangles

Current Alzheimer ResearchSeptember 2, 2019
Anurag Kumar SinghSantosh Kumar Singh
1
bioRxiv

A distinct neutrophil population invades the central nervous system during pancreatic cancer

bioRxivJune 3, 2019
Kevin Glenn BurfeindDaniel L Marks
8
5
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association

Fisetin improves lead-induced neuroinflammation, apoptosis and synaptic dysfunction in mice associated with the AMPK/SIRT1 and autophagy pathway

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research AssociationSeptember 17, 2019
Wei Ping YangChan-Min Liu
1
Journal of Neuroinflammation

STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes

Journal of NeuroinflammationJuly 8, 2019
Mei Xin ChenHe-ping Xu
1
2
Cell Death & Disease

Microglial TREM-1 receptor mediates neuroinflammatory injury via interaction with SYK in experimental ischemic stroke

Cell Death & DiseaseJuly 19, 2019
Peng-Fei XuGe-Lin Xu
1
Immunology

Sirtuin4 suppresses the anti-neuroinflammatory activity of infiltrating regulatory T cells in the traumatically injured spinal cord

ImmunologySeptember 28, 2019
Wen-Ping LinLi-Qun Zhang
2
1
Stem Cells International

Human Umbilical Cord Mesenchymal Stem Cells Attenuate Ocular Hypertension-Induced Retinal Neuroinflammation via Toll-Like Receptor 4 Pathway

Stem Cells InternationalOctober 15, 2019
Shang-Li JiShi-Bo Tang
Journal of Neuroinflammation

Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway

Journal of NeuroinflammationJuly 18, 2019
Morena ZussoStefano Moro
1
4
EMBO Molecular Medicine

Inflammasomes in neuroinflammatory and neurodegenerative diseases

EMBO Molecular MedicineApril 23, 2019
Sofie VoetGeert van Loo
6
62
bioRxiv

Loss of tissue non-specific alkaline phosphatase (TNAP) enzyme activity in cerebral microvessels is coupled to persistent neuroinflammation and behavioral deficits in late sepsis

bioRxivAugust 12, 2019
Divine C NwaforCandice M Brown
3
1
Frontiers in Pharmacology

Fast Green FCF Attenuates Lipopolysaccharide-Induced Depressive-Like Behavior and Downregulates TLR4/Myd88/NF-κB Signal Pathway in the Mouse Hippocampus

Frontiers in PharmacologyMay 8, 2019
Jing YangXiaowei Chen
1
1
International Journal of Molecular Sciences

High and Low Molecular Weight Hyaluronic Acid Differentially Influences Oxylipins Synthesis in Course of Neuroinflammation

International Journal of Molecular SciencesAugust 9, 2019
Dmitry V ChistyakovMarina G Sergeeva
Shock

Persistent Neuroinflammation and Brain Specific Immune Priming in A Novel Survival Model of Murine Pneumosepsis

ShockAugust 13, 2019
Scott J DenstaedtBenjamin H Singer
Dementia and Neurocognitive Disorders

A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation

Dementia and Neurocognitive DisordersJune 1, 2019
Seunghyun L KimK-ARPI
1
1
6
Frontiers in Pharmacology

A Bcr-Abl Inhibitor GNF-2 Attenuates Inflammatory Activation of Glia and Chronic Pain

Frontiers in PharmacologyMay 20, 2019
Gyun Jee SongKyoungho Suk
2
1

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2019 Meta ULC. All rights reserved
/feed-previews/grip1-in-myeloid-cells-in-neuroinflammation/b403386c-83cd-4fdd-bfdb-a6d684f878f7